Home › Companies › AngioDynamics, Inc. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AngioDynamics, Inc.’s Form 8-K, filed November 15, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of November 12, 2024: 6 items on AngioDynamics, Inc.’s Form 8-K, filed November 15, 2024: 3 elected · 3 approved.
Notable dissent: 1 director (12.3% against); 1 equity or compensation plan (17.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore AngioDynamics, Inc. in the interactive database Compare manager voting policies
These tallies are AngioDynamics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed November 15, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Lorinda A. Burgess | 26,292,870 | -- | -- | 1,996,095 | 5,993,164 | 93% | Elected | — |
| Elect Director: Wesley E. Johnson, Jr. | 24,817,356 | -- | -- | 3,471,609 | 5,993,164 | 88% | Elected | — |
| Elect Director: Karen A. Licitra | 26,276,748 | -- | -- | 2,012,217 | 5,993,164 | 93% | Elected | — |
| 2. Proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2025 | 34,110,530 | 155,077 | 16,522 | -- | -- | 99.5% | Approved | — |
| 3. Proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers | 26,004,908 | 1,248,479 | 1,035,578 | -- | 5,993,164 | 95% | Approved | — |
| 4. Proposal to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan | 23,195,346 | 5,058,468 | 35,151 | -- | 5,993,164 | 82% | Approved | — |
Source: AngioDynamics, Inc., Form 8-K, filed with the SEC on November 15, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
157 asset managers disclosed a vote on at least one AngioDynamics, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect three Class III directors, for a term of three years: Karen A. Licitra
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Karen A. Licitra”): 26,276,748 for, 2,012,217 withheld, per its Form 8-K filed November 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class III director to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 10,417,859 for, 143 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect three Class III directors, for a term of three years: Lorinda A. Burgess
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Lorinda A. Burgess”): 26,292,870 for, 1,996,095 withheld, per its Form 8-K filed November 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class III director to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 10,417,859 for, 143 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Proposal to elect three Class III directors, for a term of three years: Wesley E. Johnson, Jr.
AngioDynamics, Inc.’s own tally for this item (“Elect Director: Wesley E. Johnson, Jr.”): 24,817,356 for, 3,471,609 withheld, per its Form 8-K filed November 15, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The nominees for election to the Board of Directors were elected, each as a Class III director to serve until the 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, based upon the following votes:”
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 10,202,915 for, 215,087 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 100,828 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 83,500 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 0 | 0 | 0 | 27,779 | Withhold |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
82% Approved · of votes cast
Prior year: 90.7% for (November 14, 2023 meeting) ▼ 8.6 pts
Description as filed by funds: Approval of an amendment to increase the number of shares available for issuance under the AngioDynamics, Inc. 2020 Equity Incentive Plan.
AngioDynamics, Inc.’s own tally for this item (“4. The proposal to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan”): 23,195,346 for, 5,058,468 against — passed, per its Form 8-K filed November 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to approve the amended AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes:”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 55 asset managers below reported 9,117,545 for, 1,355,978 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 0 | 941,141 | 0 | 0 | Against |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 216,951 | 0 | 0 | Against |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 71,365 | 63,700 | 0 | 0 | Mixed |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| Manatuck Hill Partners, LLC | 96,097 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,727 | 30,192 | 0 | 0 | Mixed |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 0 | 52,879 | 0 | 0 | Against |
| Voya | 42,267 | 0 | 0 | 0 | For |
| Putnam | 0 | 31,987 | 0 | 0 | Against |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. All 55 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 91.8% for (November 14, 2023 meeting) ▲ 3.7 pts
Description as filed by funds: Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers.
AngioDynamics, Inc.’s own tally for this item (“3. The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers”): 26,004,908 for, 1,248,479 against — passed, per its Form 8-K filed November 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to approve, on an advisory basis, AngioDynamics' executive compensation of its named executive officers was approved based upon the following votes:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 0 | 27,779 | 0 | 0 | Against |
Fund voting reports, all 53 managers: 10,390,223 for, 27,779 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,116,852 | 0 | 0 | 0 | For |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 1,370,954 | 12,060 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 967,940 | 0 | 0 | 0 | For |
| Nuveen | 943,296 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 892,302 | 0 | 0 | 0 | For |
| Renaissance | 777,346 | 0 | 0 | 0 | For |
| State Street | 745,953 | 0 | 0 | 0 | For |
| Two Sigma | 717,026 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 450,922 | 0 | 0 | Against |
| SEGALL BRYANT & HAMILL, LLC | 432,785 | 0 | 0 | 0 | For |
| Royce | 396,663 | 0 | 0 | 0 | For |
| First Eagle Investment Management, LLC | 384,614 | 0 | 0 | 0 | For |
| Orion Porfolio Solutions, LLC | 337,824 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Northern Trust | 316,836 | 0 | 0 | 0 | For |
| JPMorgan | 315,488 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 275,048 | 0 | 0 | 0 | For |
| Point72 | 273,325 | 0 | 0 | 0 | For |
| DE Shaw | 234,409 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 219,151 | 0 | 0 | 0 | For |
| Dimensional | 209,974 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 186,881 | 0 | 0 | 0 | For |
| Mitsubishi UFJ Asset Management Co., Ltd. | 184,230 | 0 | 0 | 0 | For |
| Citadel | 168,774 | 0 | 0 | 0 | For |
| Allianz | 0 | 166,156 | 0 | 0 | Against |
Institutional-manager reports, all 121 managers: 14,906,933 for, 768,779 against, 982 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Prior year: 100.0% for (November 14, 2023 meeting) ▼ 0.4 pts
Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as AngioDynamics, Inc. independent registered public accounting firm for the fiscal year ending May 31, 2025.
AngioDynamics, Inc.’s own tally for this item (“2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2025”): 34,110,530 for, 155,077 against — passed, per its Form 8-K filed November 15, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics' independent registered public accounting firm for the fiscal year ending May 31, 2025 was approved based upon the following votes:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 10,417,859 for, 143 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,252,366 | 0 | 0 | 0 | For |
| BlackRock | 1,914,079 | 0 | 0 | 0 | For |
| Dimensional | 1,086,122 | 0 | 0 | 0 | For |
| Fidelity | 984,937 | 0 | 0 | 0 | For |
| TIAA | 941,141 | 0 | 0 | 0 | For |
| Royce | 569,410 | 0 | 0 | 0 | For |
| FIRST EAGLE FUNDS | 348,896 | 0 | 0 | 0 | For |
| Charles Schwab | 330,130 | 0 | 0 | 0 | For |
| Transamerica | 319,900 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 216,951 | 0 | 0 | 0 | For |
| Segall Bryant & Hamill Trust | 205,620 | 0 | 0 | 0 | For |
| Nationwide | 150,936 | 0 | 0 | 0 | For |
| Equitable | 135,065 | 0 | 0 | 0 | For |
| JPMorgan | 129,467 | 0 | 0 | 0 | For |
| Invesco | 100,828 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 83,500 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 71,654 | 0 | 0 | 0 | For |
| Lincoln Financial | 62,919 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 54,079 | 0 | 0 | 0 | For |
| American Century | 52,879 | 0 | 0 | 0 | For |
| Voya | 42,267 | 0 | 0 | 0 | For |
| GuideStone | 40,606 | 0 | 0 | 0 | For |
| Putnam | 31,987 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 31,117 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 27,779 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 41,004,249 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.49% |
| 2 | BlackRock | 4.67% |
| 3 | Dimensional | 2.65% |
| 4 | Fidelity | 2.40% |
| 5 | TIAA | 2.30% |
| 6 | Royce | 1.39% |
| 7 | FIRST EAGLE FUNDS | 0.85% |
| 8 | Charles Schwab | 0.81% |
| 9 | Transamerica | 0.78% |
| 10 | Columbia Threadneedle | 0.53% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 5.16% |
| 2 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 3.37% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 2.36% |
| 4 | Nuveen | 2.30% |
| 5 | ARMISTICE CAPITAL, LLC | 2.18% |
| 6 | Renaissance | 1.90% |
| 7 | State Street | 1.82% |
| 8 | Two Sigma | 1.75% |
| 9 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 1.10% |
| 10 | SEGALL BRYANT & HAMILL, LLC | 1.06% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 3,596,042 | 8.77% | Form 13F, quarter ended March 31, 2025 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,508,295 | 6.12% | Schedule 13G, filed February 10, 2026 |
| Vanguard Group | 2,492,563 | 6.08% | Form 13F, quarter ended March 31, 2025 |
| KEVIN KOTLER | 2,421,526 | 5.91% | Schedule 13G, filed February 9, 2026 |
| Integrated Core Strategies (US) LLC | 2,124,268 | 5.18% | Schedule 13G, filed July 22, 2025 |
| Armistice Capital, LLC | 1,527,815 | 3.73% | Schedule 13G, filed August 14, 2025 |
| Nuveen | 1,296,366 | 3.16% | Form 13F, quarter ended March 31, 2025 |
| Millennium Management | 1,239,572 | 3.02% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 1,165,569 | 2.84% | Form 13F, quarter ended March 31, 2025 |
| James C. Clemmer | 1,117,665 | 2.73% | Proxy statement (DEF 14A), proxy filed September 25, 2025 |
Percentages above are of 41,004,249 shares outstanding, as reported by AngioDynamics, Inc. on its Form 10-Q dated August 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AngioDynamics, Inc.'s shareholder meeting held November 12, 2024, in the 2024-2025 proxy season, 157 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 1,148 separate fund positions. On the most widely held item on that ballot — Say-on-Pay - An advisory vote on the approval of compensation of our named executive officers. — AngioDynamics, Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AngioDynamics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on November 15, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AngioDynamics, Inc.’s 10-Q dated August 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AngioDynamics, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “AngioDynamics (ANGO) 2024 Annual Meeting (2024-2025 season)”, https://proxyvotesnow.com/company/angiodynamics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.